CSL

CSL Limited, founded in 1916 as Commonwealth Serum Laboratories, is an Australian multinational biotechnology company dedicated to researching, developing, manufacturing, and marketing products that treat and prevent serious human medical conditions. The company's core mission is to save lives and protect public health through innovative biotechnological solutions. CSL's product portfolio includes blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in medical and genetic research. The company serves global markets with a focus on addressing unmet medical needs.

Notable affiliated entities include CSL Behring, CSL Seqirus, and CSL Vifor, which contribute to the company's extensive expertise in biotechnology. CSL has achieved significant milestones, such as securing a U.S. government award for avian influenza preparedness and consistently delivering strong financial results. The company's impact is profound, with over a century of contributions to public health and ongoing advancements in biotechnological research and development.